SG11201706335TA - Host cell protein modification - Google Patents

Host cell protein modification

Info

Publication number
SG11201706335TA
SG11201706335TA SG11201706335TA SG11201706335TA SG11201706335TA SG 11201706335T A SG11201706335T A SG 11201706335TA SG 11201706335T A SG11201706335T A SG 11201706335TA SG 11201706335T A SG11201706335T A SG 11201706335TA SG 11201706335T A SG11201706335T A SG 11201706335TA
Authority
SG
Singapore
Prior art keywords
host cell
cell protein
protein modification
modification
host
Prior art date
Application number
SG11201706335TA
Inventor
Darya Burakov
Michael Goren
Gang Chen
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55538620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201706335T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201706335TA publication Critical patent/SG11201706335TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
SG11201706335TA 2015-02-27 2016-02-26 Host cell protein modification SG11201706335TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562126213P 2015-02-27 2015-02-27
US201662298869P 2016-02-23 2016-02-23
PCT/US2016/019915 WO2016138467A1 (en) 2015-02-27 2016-02-26 Host cell protein modification

Publications (1)

Publication Number Publication Date
SG11201706335TA true SG11201706335TA (en) 2017-09-28

Family

ID=55538620

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201706335TA SG11201706335TA (en) 2015-02-27 2016-02-26 Host cell protein modification

Country Status (20)

Country Link
US (1) US20160251411A1 (en)
EP (1) EP3262168B1 (en)
JP (1) JP6751402B2 (en)
KR (1) KR20170120126A (en)
CN (1) CN107406831A (en)
AU (1) AU2016224988A1 (en)
BR (1) BR112017018149A2 (en)
CA (1) CA2976669A1 (en)
DK (1) DK3262168T3 (en)
EA (1) EA201791918A1 (en)
ES (1) ES2751670T3 (en)
HK (1) HK1248272A1 (en)
HU (1) HUE045862T2 (en)
IL (1) IL253863A0 (en)
MX (1) MX2017011012A (en)
MY (1) MY180896A (en)
SG (1) SG11201706335TA (en)
TW (1) TW201702380A (en)
WO (1) WO2016138467A1 (en)
ZA (1) ZA201705712B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018039499A1 (en) * 2016-08-24 2018-03-01 Regeneron Pharmaceuticals, Inc. Host cell protein modification
CN116327963A (en) 2016-11-21 2023-06-27 济世-伊沃泰克生物制品有限公司 Ophthalmic preparation and application thereof
CA3067735A1 (en) 2017-08-17 2019-02-21 Just Biotherapeutics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants
JP2021521873A (en) * 2018-05-04 2021-08-30 シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニーSigma−Aldrich Co. LLC Manipulated cells with modified host cell protein profile
SG11202009499VA (en) * 2018-05-04 2020-11-27 Sigma Aldrich Co Llc Producing recombinant proteins with reduced levels of host cell proteins
US20210096130A1 (en) * 2019-09-12 2021-04-01 Lonza Ltd Compositions, methods, and kits for detection of lipolytic activity
MX2022004311A (en) 2019-10-15 2022-05-10 Lilly Co Eli Recombinantly engineered, lipase/esterase-deficient mammalian cell lines.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734936T2 (en) * 1996-09-19 2006-08-24 Novozymes A/S HOST CELLS AND METHODS FOR PRODUCING PROTEINS
EP2150617B1 (en) 2007-06-04 2014-10-22 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
GB201000587D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
CN104066439A (en) * 2011-07-29 2014-09-24 十一生物治疗股份有限公司 Purified proteins
US8697359B1 (en) * 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
WO2015038888A1 (en) 2013-09-13 2015-03-19 Genentech, Inc. Methods and compositions comprising purified recombinant polypeptides
RU2016107435A (en) * 2013-09-13 2017-10-18 Дженентек, Инк. COMPOSITIONS AND METHODS FOR DETECTING AND QUANTITATIVE DETERMINATION OF THE PROTEIN OF CELLS-OWNERS IN CELL LINES AND RECOMBINANT POLYPEPTIDE PRODUCTS
US9932591B2 (en) * 2013-12-18 2018-04-03 University Of Delaware Reduction of lipase activity in product formulations

Also Published As

Publication number Publication date
EA201791918A1 (en) 2017-12-29
CA2976669A1 (en) 2016-09-01
MX2017011012A (en) 2017-10-20
HUE045862T2 (en) 2020-01-28
JP6751402B2 (en) 2020-09-02
MY180896A (en) 2020-12-11
EP3262168A1 (en) 2018-01-03
WO2016138467A1 (en) 2016-09-01
TW201702380A (en) 2017-01-16
KR20170120126A (en) 2017-10-30
HK1248272A1 (en) 2018-10-12
DK3262168T3 (en) 2019-10-07
AU2016224988A1 (en) 2017-09-07
EP3262168B1 (en) 2019-08-21
BR112017018149A2 (en) 2018-04-10
IL253863A0 (en) 2017-09-28
JP2018506295A (en) 2018-03-08
CN107406831A (en) 2017-11-28
ES2751670T3 (en) 2020-04-01
US20160251411A1 (en) 2016-09-01
ZA201705712B (en) 2020-01-29

Similar Documents

Publication Publication Date Title
GB201502305D0 (en) Protein
GB201502306D0 (en) Protein
IL252696A0 (en) Protein manufacture
HK1248272A1 (en) Host cell protein modification
GB201515745D0 (en) Proteins
GB201511787D0 (en) Proteins
PL3099791T3 (en) Protein
EP3164410B8 (en) Protein recovery
EP3463414C0 (en) Protein interfaces
GB201415344D0 (en) Protein
IL256298A (en) Multi-specific binding proteins
PL3099793T3 (en) Protein
EP3132031A4 (en) Carbohydrate-binding protein
GB201418713D0 (en) Bindings Proteins
EP3364744A4 (en) High protein oat species
GB201513033D0 (en) Proteins
SG10201910999TA (en) Native protein purification technology
GB201522610D0 (en) Protein
GB201515744D0 (en) Proteins
GB201503778D0 (en) Proteins
GB201515337D0 (en) Protein Expression
GB201419897D0 (en) Host cell
GB201412797D0 (en) Proteins
GB201412646D0 (en) Proteins
GB201412648D0 (en) Proteins